Cite
HARVARD Citation
Früh, M. et al. (2020). Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. Lung cancer. pp. 6-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Früh, M. et al. (2020). Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. Lung cancer. pp. 6-11. [Online].